Have a question or topic idea for The Life Science Report? Submit it here.
The Next Innovations in Gene Therapies: What’s to Come as The Industry Moves Forward
Dr. Peter Bak talks to Brendan Wang and Kyle O’Neil of Back Bay Life Science Advisors about the field of gene therapies and insights from their recently authored piece in Cell & Gene, “The Next Decade In Gene Therapy Innovation — 6 Critical Questions (And Answers),” and their newly released white paper, “The Next Decade of Gene Therapy Innovation.”
Gene therapy has been talked about for many years, and it’s only in the past few years that we have started to see some initial products make it to market. When many people think about gene therapies, they think they will be a curative treatment, but commercial positioning, pricing and the business model of gene therapies are still in flux.
Topics in this podcast include:
The scientific and commercial challenges of gene therapies
How the space is evolving from a commercial standpoint
The complicated issue of delivery
The investment of gene therapy & the outcome-based gene therapy business models
Risk-sharing agreements, payment methodologies & pricing models.
Subscribe to Back Bay's Life Science Report podcast on any major podcast player. Please join the conversation: send us your comments and questions.
Subscribe:
Apple Podcasts | Libsyn | Spotify | Stitcher
